NOTIFICATION TO STOCK EXCHANGE
COMPANY STATEMENT
Karnataka, Bengaluru, India, June 08, 2023
This is to inform you that our Active Pharmaceutical Ingredient (API) manufacturing facility located in Bangalore has received a certificate of GMP compliance from the Competent Authority of Germany, following an EU GMP inspection that was conducted in February 2023.
Download Company Statement
